Younger age at multiple sclerosis onset is associated with worse outcomes at age 50.
Gauruv BoseBrian C HealyChristian BarroBonnie I GlanzHrishikesh A LokhandeMariann Polgar-TurcsanyiCharles Rg GuttmannRohit BakshiHoward L WeinerTanuja ChitinisPublished in: Journal of neurology, neurosurgery, and psychiatry (2022)
All outcomes at age 50 were worse in patients with younger age at onset. Decisions to provide high-efficacy treatments should consider younger age at onset, equating to a longer expected disease duration, as a poor prognostic factor.